Status:

UNKNOWN

Risk Stratification and Minimally Invasive Surgery in Acute ICH Patients

Lead Sponsor:

First Affiliated Hospital of Fujian Medical University

Collaborating Sponsors:

National Health and Family Planning Commission, P.R.China

Conditions:

Spontaneous Intracerebral Hemorrhage

Eligibility:

All Genders

18-80 years

Brief Summary

The study consists of 2 parts: the first part is to conduct a multicenter retrospective analysis of more than 1000 acute ICH patients treated by conservative observation from 33 centers in China to cr...

Detailed Description

Spontaneous intracerebral hemorrhage (ICH) accounts for 2 million strokes worldwide per year and is the deadliest subtype of stroke with a 1-year mortality rate up to 50%. Given the high morbidity and...

Eligibility Criteria

Inclusion

  • Retrospective part
  • Emergent CT showed a spontaneous supratentorial intracerebral hemorrhage (patient with a small amount of intraventricular hemorrhage is eligible);
  • Patients should have undergone baseline CT scan within 48 hours after hemorrhage onset and repeated fewer than 48 hours after the baseline CT;
  • Patients without herniation.
  • Patients were treated by observation before hemorrhage growth (if happened).

Exclusion

  • Spontaneous intracerebral hemorrhage secondary to an underlying structural cause identified by brain imaging, (ie, vascular malformation, aneurysm, tumor);
  • The time from symptom onset to baseline imaging was not known in hours, clinical information or lab results was not enough to determine the growth of the hematoma or to perform statistical analysis;
  • Patients had accepted acute treatment that might have reduced intracerebral hemorrhage volume (ie, surgical evacuation, external ventricular drainage, lumbar puncture).
  • Prospective part
  • Inclusion Criteria:
  • Emergent CT showed a spontaneous supratentorial intracerebral hemorrhage (patient with a small amount of intraventricular hemorrhage is eligible);
  • Patients without herniation meet the clinical uncertainty principle as follows: the responsible neurosurgeon is uncertain about the benefits of surgery.
  • Patients should have undergone baseline CT scan within 24 hours after hemorrhage onset; the volume of the hematoma is more than 20 ml and less than 100ml on the first CT scan.
  • Patients with a Glasgow coma score of 5 or more.
  • Informed consent, and willing to accept long-term follow-up.

Key Trial Info

Start Date :

July 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 31 2022

Estimated Enrollment :

1300 Patients enrolled

Trial Details

Trial ID

NCT03862729

Start Date

July 1 2019

End Date

March 31 2022

Last Update

November 22 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The first affiliated hospital of fujian medical university

Fuzhou, Fujian, China, 350005